TMCI / Treace Medical: New Surgeons, Higher ASPs, And More Lapiplasties: A Positive Trend

Treace Medical Concepts, Inc. sells medical device treatments for foot bunions. The global market for bunion correction systems is forecasted to reach more_horizontal

PONTE VEDRA, Fla., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical tec more_horizontal

Treace Medical Concepts continues to present with attractive economic characteristics. TMCI has penetrated 5.8% of the $5bn US bunion surgery market, more_horizontal

Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Vivian Cervantes - IR, Gilma more_horizontal

Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions mig more_horizontal

Treace Medical focuses on medical equipment therapies to treat bunions. The company released fourth-quarter and full-year earnings after the markets c more_horizontal

Treace Medical Concepts (TMCI) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on t more_horizontal

Treace Medical Concepts, Inc. has a key differentiator in its Lapiplasty procedure, with the potential to create a remedial breakthrough. The company more_horizontal